Hester Biosciences Reports Robust Q2 Profit Growth Amid Strategic Shift
Published on: Nov. 12, 2025, 3:46 p.m. | Source: Devdiscourse
Hester Biosciences announced a remarkable 71% increase in its net profit for the second quarter of 2025, reaching Rs 14.33 crore. The company is focusing on reducing dependency on tender-based revenues to ensure business resilience. Operating revenue was reported at Rs 70.97 crore, reflecting strategic realignment.
